US 11,806,317 B2
Composition capable of promoting testosterone secretion and use thereof
Yung-Hsiang Lin, Taipei (TW); I-Hui Chen, Taipei (TW); Kai-Wen Kan, Taipei (TW); Fu Chen Liu, Taipei (TW); and Ciao-Ting Chen, Taipei (TW)
Assigned to TCI CO., LTD., Taipei (TW)
Appl. No. 16/499,350
Filed by TCI CO., LTD, Taipei (TW)
PCT Filed Apr. 3, 2018, PCT No. PCT/CN2018/081709
§ 371(c)(1), (2) Date Sep. 30, 2019,
PCT Pub. No. WO2018/184523, PCT Pub. Date Oct. 11, 2018.
Claims priority of provisional application 62/503,185, filed on May 8, 2017.
Claims priority of provisional application 62/480,860, filed on Apr. 3, 2017.
Prior Publication US 2020/0030396 A1, Jan. 30, 2020
Int. Cl. A61K 36/185 (2006.01); A23L 33/105 (2016.01); A61K 9/00 (2006.01); A61K 9/08 (2006.01); A61K 9/48 (2006.01); A61P 3/04 (2006.01); A61K 31/01 (2006.01); A61K 31/015 (2006.01); A61K 36/21 (2006.01); A61K 36/258 (2006.01); A61K 36/31 (2006.01); A61K 36/45 (2006.01); A61K 36/48 (2006.01); A61K 36/53 (2006.01); A61K 36/67 (2006.01); A61K 36/73 (2006.01); A61K 36/74 (2006.01); A61K 36/752 (2006.01); A61K 36/815 (2006.01); A61K 36/82 (2006.01); A61K 36/87 (2006.01); A61K 36/886 (2006.01); A61K 36/8962 (2006.01); A61K 36/9066 (2006.01); A61K 8/9789 (2017.01); A61P 17/16 (2006.01); A61Q 19/00 (2006.01); A23F 3/16 (2006.01); A61K 8/97 (2017.01); A61Q 17/04 (2006.01); A61P 19/04 (2006.01); A61Q 19/08 (2006.01)
CPC A61K 36/185 (2013.01) [A23F 3/163 (2013.01); A23L 33/105 (2016.08); A61K 8/97 (2013.01); A61K 8/9789 (2017.08); A61K 9/0056 (2013.01); A61K 9/0095 (2013.01); A61K 9/08 (2013.01); A61K 9/48 (2013.01); A61K 31/01 (2013.01); A61K 31/015 (2013.01); A61K 36/21 (2013.01); A61K 36/258 (2013.01); A61K 36/31 (2013.01); A61K 36/45 (2013.01); A61K 36/48 (2013.01); A61K 36/53 (2013.01); A61K 36/67 (2013.01); A61K 36/73 (2013.01); A61K 36/74 (2013.01); A61K 36/752 (2013.01); A61K 36/815 (2013.01); A61K 36/82 (2013.01); A61K 36/87 (2013.01); A61K 36/886 (2013.01); A61K 36/8962 (2013.01); A61K 36/9066 (2013.01); A61P 3/04 (2018.01); A61P 17/16 (2018.01); A61P 19/04 (2018.01); A61Q 17/04 (2013.01); A61Q 19/007 (2013.01); A61Q 19/08 (2013.01); A23V 2002/00 (2013.01)] 3 Claims
 
1. A method for promoting secretion of testosterone, comprising administering to a subject in need thereof an effective amount of a composition comprising 0.5 mg/ml of a red wine extract and 0.5 mg/ml of a Four Seasons Spring tea extract.